Disclosure on Related Party Transactions for the half year ended 30th September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Astonea Labs Ltd has submitted its mandatory half-yearly disclosure of related party transactions to BSE under SEBI LODR Regulation 23(9). Total transaction value during the reporting period stood at ₹2,062.60 lakhs (~₹20.6 crore). The largest single transaction was sale of goods/services to associate company Astonea One Pvt Ltd at ₹1,261.30 lakhs, followed by sales to Ascot Biolabs (₹100.49 lakhs). Loans to relatives Harish Gulati and Usha Gulati stood at ₹237.35 lakhs and ₹214.50 lakhs respectively, while loans to associate Ascot Biolabs grew from ₹0.78L to ₹17.39L. Managing Director Ashish Gulati received ₹10.86 lakhs in remuneration; CFO Sumit Kumar received ₹0.65 lakhs and Independent Directors collectively received sitting fees of ₹1.56 lakhs during the half year.
This is a routine compliance disclosure and does not directly impact stock price, but investors should note the heavy dependence on the promoter-family-linked Astonea One Pvt Ltd for sales (₹12.6 crore in six months) and significant inter-company loans with relatives and associates, which warrant ongoing scrutiny for governance and arm's-length pricing.